Along this line, a recent paper confirmed chronic NFAT activation in ABC-DLBCL controlling IL10 production and demonstrated the efficacy of calcineurin inhibitors in blocking NFAT signaling and reducing proliferation. The gene discussed is IL10; the disease is diffuse large B-cell lymphoma.